Smith Thornton Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Buy
4,351
+21
+0.5% +$5.54K 0.5% 50
2026
Q2
$1.12M Buy
4,330
+149
+4% +$34.7K 0.49% 53
2026
Q1
$1.02M Sell
4,181
-21
-0.5% -$4.89K 0.51% 52
2025
Q4
$870K Buy
4,202
+36
+0.9% +$7.12K 0.44% 57
2025
Q3
$773K Buy
4,166
+118
+3% +$20.2K 0.41% 61
2025
Q2
$618K Buy
4,048
+104
+3% +$16K 0.36% 69
2025
Q1
$654K Buy
3,944
+35
+0.9% +$5.48K 0.41% 63
2024
Q4
$565K Buy
3,909
+96
+3% +$14.9K 0.36% 71
2024
Q3
$618K Buy
3,813
+241
+7% +$38.4K 0.41% 70
2024
Q2
$522K Buy
+3,572
New +$531K 0.38% 71

Other funds holding JNJ

Smith Thornton Advisors's JNJ Position: Q3 2026 in Review

Smith Thornton Advisors increased its Johnson & Johnson (JNJ) stake by 0.48% in Q3 2026, buying an estimated $5.54K and bringing the position to 4,351 shares worth $1.15M. The position accounts for 0.5% of the portfolio, ranked #50.

Smith Thornton Advisors first reported a position in JNJ in Q2 2024 and has held it in 10 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Smith Thornton Advisors held 4,351 shares of Johnson & Johnson worth $1.15M as of Q3 2026.
  • Smith Thornton Advisors bought 21 Johnson & Johnson shares in Q3 2026, an estimated $5.54K.
  • Johnson & Johnson made up 0.5% of Smith Thornton Advisors's portfolio in Q3 2026, its #50 holding.
  • Smith Thornton Advisors first reported a position in Johnson & Johnson in Q2 2024 and has held it in 10 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Smith Thornton Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.